Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, December 06, 2017
Plasticell announced it will collaborate with Anthony Nolan to progress clinical development of Plasticell’s ex vivo expanded cord-blood derived hematopoietic stem cell product.
read more
Plasticell, a developer of stem cell technologies and cell-based therapies, has signed agreements with the Agency for Science, Technology and Research (A*STAR) and the Nanyang Technological University (NTU) to progress its therapeutic stem cell ...
read more
Plasticell, the biotechnology company using combinatorial technologies for stem cell research and the optimization of cell and gene therapy manufacturing, has announced the signing of a collaboration agreement with the National University of Ireland,...
read more
Wednesday, April 19, 2017
Plasticell, a developer of cell therapies including hematopoietic cell replacement therapies, has partnered with Kings College London to progress preclinical trials of its artificial blood platelet product, manufactured from pluripotent stem cells. ...
read more
Thursday, September 22, 2016
Plasticell, the biotechnology company using combinatorial technologies for stem cell research and optimization of cell and gene therapy manufacturing, has announced it is collaborating with CellSpring, an innovative company that has developed a high ...
read more
Tuesday, January 14, 2025
With this move, PLD is consolidating its divisions with a unified identity that reflects the company’s commitment to developing and manufacturing high quality, liquid and solid dose OTC and Rx products to its customers.
read more
PL BioScience GmbH announced a significant expansion of company headquarters and future manufacturing capabilities to meet the rapidly growing global demand for safe, animal-free cell culture supplements.
read more
PL BioScience GmbH, a German life science company specializing in the production and development of Human Platelet Lysate (HPL) for cell expansion, announced the signing of a Letter of Intent (LOI) with the Korean biotech company DewCell ...
read more
Wednesday, February 28, 2018
ProJect Pharmaceutics announces that it has extended its safety facilities by laboratories dedicated to handle GMO S2 and BSL-2 based biological products.
read more
Tuesday, December 29, 2015
PixarBio Corporation announced today the appointment of Steven Chartier as V.P. of Regulatory Affairs.
read more
Friday, December 22, 2017
PixarBio developers of NeuroRelease NR14 announce an agreement between PSI, a Lubrizol Corporation Company, to cGMP manufacture PixarBio’s NR14.
read more
Tuesday, January 29, 2019
Pivot announced the company has entered into a contract manufacturing agreement with Growpacker to produce Pivot's topical gels, creams and beverages for the California cannabis market.
read more
The Pistoia Alliance, a global, not-for-profit alliance that advocates for greater collaboration in life sciences R&D, is launching two complementary initiatives to transform pharmacovigilance (PV) in response to growing member demand.
read more
Piramal Pharma Solutions (PPS) announced that its Grangemouth, UK facility has completed production of its 1,500th antibody-drug conjugate (ADC) batch. The milestone batch represents a commercial oncology product.
read more
Thursday, September 19, 2024
Piramal Pharma Limited embarked on its sustainability journey as the Science Based Targets initiative (SBTi) officially validated the company’s near-term greenhouse gas (GHG) emission reduction targets.
read more